对l-theanine合成酶与基于PPK2的ATP再生在没有缓冲区和Mn2+优化的条件下进行比较评估
Kyungjae Yu1, Hyun Gi Koh1, Byung Wook Lee1
1Department of Biological and Chemical Engineering, Hongik University, Sejong 30016, Republic of Korea.
Enzyme and microbial technology
|February 28, 2026
概括
这项研究表明,使用工程化大肠杆菌 (E. coli) 进行有效的l-theanine生产. 本源的-氨基氨基合成酶 (GCS) 酶显示出作为生产这种功能性氨基酸的替代生物催化剂的希望.
科学领域:
- 生物技术是生物技术.
- 生物催化剂是一种生物催化剂.
- 代谢工程是代谢工程.
背景情况:
- 氨酸是一种有价值的氨基酸,具有多种营养学应用.
- 目前的生产主要依赖于胺甲基胺合成酶 (GMAS).
- -氨基氨酸合成酶 (GCS) 对l-theanine生物合成的潜力在很大程度上尚未被探索.
研究的目的:
- 建立一个全细胞生物转化系统,用于生产l-氨酸.
- 评估本地大肠杆菌GCS (ecGCS) 作为生物催化剂的疗效.
- 使用多酸盐激酶2 (PPK2) 变体优化ATP再生.
主要方法:
- 工程化埃舍里希亚大肠杆菌菌株表达甲基菌可能GMAS (MmGMAS) 或大肠杆菌GCS (ecGCS).
- 集成的ATP再生系统使用聚酸激酶2 (PPK2).
- 高基板,没有缓冲区的全细胞转换系统.
主要成果:
- 在分析预测ecGCS的催化效率与MmmGMAS相比.
- Rhodobacter sphaeroides PPK2 (PPK2-6) 优化了ATP再生,减少了约90%的ATP输入.
- 两种MmmGMAS-PPK2-6和ecGCS-PPK2-6系统都实现了高的l-theanine产量 (分别为47.9g/L和44.5g/L).
结论:
- 使用本地ecGCS的高效l-theanine生产在与过程相关的条件下首次被证明.
- 基于ecGCS的系统为GMAS生物合成提供了一个有前途的替代或补充平台.
- 没有缓冲区的条件有助于生产,并可能简化下游加工.
相关概念视频
ATP Driven Pumps I: An Overview
10.1K
ATP-driven pumps, also known as transport ATPases, are integral membrane proteins. They have binding sites for ATP located on the membrane's cytosolic side and the ion-conducting domain in the transmembrane region. These pumps use the free energy released from ATP hydrolysis to move the solutes across cell membranes against an electrochemical gradient.
There are four main types of ATP-driven pumps - P-type, V-type, F-type, and ABC transporter. All these pumps are of varying complexities and...
There are four main types of ATP-driven pumps - P-type, V-type, F-type, and ABC transporter. All these pumps are of varying complexities and...
10.1K
ATP Synthase: Mechanism
18.0K
In animals, the mitochondrial F1F0 ATP synthase is the key protein that synthesizes ATP molecules through a complex catalytic mechanism. While the nuclear genome encodes the majority of ATP synthase subunits, the mitochondrial genome encodes some of the enzyme's most critical components. The formation of this multi-subunit enzyme is a complex multi-step process regulated at the level of transcription, translation, and assembly. Defects in one or more of these steps can result in decreased...
18.0K


